Clopidogrel Completed Phase 3 Trials for NSTEACS / Platelet Aggregation Inhibitors Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00325390Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation